A phase Ib single-arm study of bintrafusp alfa for the treatment of pretreated, locally advanced/unresectable or metastatic urothelial cancer.

被引：2
|
作者：
Grivas, Petros [1 ]
Morales-Barrera, Rafael [2 ]
Sridhar, Srikala S. [3 ]
Loriot, Yohann [4 ]
Van der Heijden, Michiel Simon [5 ]
Galsky, Matt D. [6 ]
Baxter, Dawn [7 ]
Khaled, Ahmed Hussein [7 ]
Hug, Bruce A. [7 ]
机构：
[1] Univ Washington, Fred Hutchinson Canc Res Ctr, Dept Med, Div Oncol,Seattle Canc Care Alliance, Seattle, WA 98195 USA
[2] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Barcelona, Spain
[3] Princess Margaret Canc Ctr, Canc Clin Res Unit, Toronto, ON, Canada
[4] Univ Paris Saclay, Inst Gustave Roussy, Dept Canc Med, Villejuif, France
[5] Netherlands Canc Inst, Amsterdam, Netherlands
[6] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Med, Div Hematol Oncol, New York, NY 10029 USA
[7] GlaxoSmithKline, Collegeville, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 06期
关键词：
D O I：
10.1200/JCO.2021.39.6_suppl.TPS501
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS501
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
    Chen, Tom Wei-Wu
    Hsu, Chia-Lang
    Hong, Ruey-Long
    Lee, Jen-Chieh
    Chang, Koping
    Yu, Chih-Wei
    Chen, San-Chi
    Guo, Jhe-Cyuan
    Chen, Mei-Lu
    Hsu, Meng-Chi
    Kung, Ting-Fang
    Cheng, Ann-Lii
    Yen, Chueh-Chuan
    CLINICAL CANCER RESEARCH, 2022, 28 (23) : 5058 - 5065
  • [32] A FIRST-IN-HUMAN PHASE I STUDY OF M6223 (TIGIT INHIBITOR) AS MONOTHERAPY OR IN COMBINATION WITH BINTRAFUSP ALFA IN PATIENTS WITH METASTATIC OR LOCALLY ADVANCED SOLID UNRESECTABLE TUMORS
    Watson, Geoffrey
    McKean, Meredith
    Tolcher, Anthony
    Victor, Anja
    Zhang, Sen
    Pierre, Vadryn
    Richter, Emilia
    Naing, Aung
    Naing, Aung
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A561 - A561
  • [33] Final Results from SAUL, a Single-arm International Study of Atezolizumab in Unselected Patients with Pretreated Locally Advanced/Metastatic Urinary Tract Carcinoma
    Sternberg, Cora N.
    Loriot, Yohann
    Choy, Ernest
    Castellano, Daniel
    Lopez-Rios, Fernando
    Banna, Giuseppe Luigi
    Zengerling, Friedemann
    De Giorgi, Ugo
    Gedye, Craig
    Masini, Cristina
    Bamias, Aristotelis
    del Muro, Xavier Garcia
    Duran, Ignacio
    Powles, Thomas
    Retz, Margitta
    Gamulin, Marija
    Geczi, Lajos
    Huddart, Robert A.
    Calabro, Fabio
    Kandula, Geetha
    Skamnioti, Pari
    Merseburger, Axel S.
    EUROPEAN UROLOGY FOCUS, 2024, 10 (06): : 938 - 946
  • [34] Treatment of advanced or metastatic hepatocellular cancer (HCC): Final clinical results of a single-arm phase II study of bevacizumab and everolimus
    Treiber, Gerhard
    Wex, Thomas
    Schneider, Guenther
    Roecken, Cristoph
    Dufour, Jean-Francois
    Geisel, Juergen
    Hardikar, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [35] Neoadjuvant chemotherapy alone with mFOLFOXIRI in locally advanced rectal cancer: A single-arm phase II study.
    Deng, Yanhong
    Zhang, Jianwei
    Cai, Yue
    Hu, Huabin
    Ling, Jiayu
    Xiao, Jian
    Huang, Meijin
    Kang, Liang
    Wang, Lei
    Lan, Ping
    Wang, Jianping
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [36] Phase 1b trial of cirmtuzumab and paclitaxel for locally advanced, unresectable and metastatic breast cancer.
    Shatsky, Rebecca
    Messer, Karen
    Helsten, Teresa L.
    Schwab, Richard B.
    Pittman, Emily I.
    Chen, Ruifeng
    Weihe, Elizabeth
    Widhopf, George
    Ghia, Emmanuela M.
    Rassenti, Laura Z.
    Alfred, Molinolo A.
    Breitmeyer, James
    Jamieson, Catriona H.
    Kipps, Thomas J.
    Parker, Barbara A.
    CANCER RESEARCH, 2021, 81 (13)
  • [37] Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study
    Harding, James J.
    Fan, Jia
    Oh, Do-Youn
    Choi, Hye Jin
    Kim, Jin Won
    Chang, Heung-Moon
    Bao, Lequn
    Sun, Hui-Chuan
    Macarulla, Teresa
    Xie, Feng
    Metges, Jean-Phillippe
    Ying, Jie'er
    Bridgewater, John
    Lee, Myung-Ah
    Tejani, Mohamedtaki A.
    Chen, Emerson Y.
    Kim, Dong Uk
    Wasan, Harpreet
    Ducreux, Michel
    Bao, Yuanyuan
    Boyken, Lisa
    Ma, Jiafang
    Garfin, Phillip
    Pant, Shubham
    LANCET ONCOLOGY, 2023, 24 (07): : 772 - 782
  • [38] Phase 1 trial of first-line bintrafusp alfa in combination with other anticancer therapies in patients (pts) with locally advanced or advanced cervical cancer.
    Oaknin, Ana
    Ghamande, Sharad A.
    Kasamatsu, Yuka
    Gil-Martin, Marta
    Diver, Elisabeth J.
    Jehl, Genevieve
    Gleicher, Stephan A.
    Chaudhary, Surendra
    Vugmeyster, Yulia
    Hasegawa, Kosei
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [39] Prospective single-arm study of intraoperative radiotherapy for locally advanced or recurrent rectal cancer
    Tan, Jennifer
    Heriot, Alexander G.
    Mackay, Jack
    Van Dyk, Sylvia
    Bressel, Mathias A. B.
    Fox, Chris D.
    Hui, Andrew C.
    Lynch, A. Craig
    Leong, Trevor
    Ngan, Samuel Y.
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2013, 57 (05) : 617 - 625
  • [40] SHR-8068 combined with adebrelimab and bevacizumab in the treatment of refractory advanced colorectal cancer: study protocol for a single-arm, phase Ib/II study
    Zhang, Pei
    Li, Xiaofen
    Wang, Xin
    Yang, Yu
    Wang, Jianfei
    Cao, Dan
    FRONTIERS IN IMMUNOLOGY, 2024, 15
12345